ANTI-CANCER DRUGS（抗癌药杂志）影响因子_期刊投稿发表

期刊简介

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

《抗癌药物》报告了与抗癌药物相关的临床和实验结果，并欢迎在抗癌药物设计、药物递送、药理学、激素和生物学模式以及化疗评估方面做出贡献。《抗癌药物》是一本国际性的杂志，致力于快速发表抗癌治疗药物的创新研究，旨在刺激和报告有毒和无毒抗癌药物的研究。因此，该杂志的范围将涵盖传统的细胞毒性化疗和激素或生物反应模式，如白细胞介素和免疫疗法。提交的文章要经过编辑的初步审查。有些文章可能会被退回给作者而不作进一步考虑。那些被考虑出版的出版物将接受编辑和来自审稿人库的被邀请者的进一步评估和同行评审。

《ANTI-CANCER DRUGS》期刊已被查看：次

分区信息